Skip to content

Clinical trials

Phase 3 Atrial Fibrillation trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atrial Fibrillation Phase: Phase 3 Country / region: Germany Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20033
20042
20052
20063
20072
20083
20091
20101
20122
20133
20142
20161
20174
20181
20193
20211
20222
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30
Terminated6
Recruiting3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi7
Bayer3
Boehringer Ingelheim3
Daiichi Sankyo3
Atrial Fibrillation Network2
Bristol-Myers Squibb2
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company2
Janssen Scientific Affairs, LLC2
Solvay Pharmaceuticals2
Advanz Pharma1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atrial Fibrillation40
Stroke7
Arrhythmias, Cardiac5
Atrial Flutter5
Cardiovascular Diseases3
Embolism2
Ischemic Stroke2
Thromboembolism2
Acute Coronary Syndrome1
Anemia1

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.